I want to end this week with an ASCO follow up and talking about something new. I must say that the sector is doing modestly better than I had feared and seems to have gotten its legs. This obviously does not mean that it is going to run but at least it does not seem […]
June 21 Biotech Update
Really not much news but the more things change the more they stay the same. We seem destined to once again test the lows in the sector and one has to worry about each test. On the positive side the support keeps holding but on the negative side each test probably increases the risk of […]
November 20 Biotech Update
The sector still cannot gain real footing and follow positive days with additional positive days. That being said as long as the positive days either outnumber or have higher gains than the losing day loses, then we can churn higher (or at the very least churn sideways and build a nice base). I am sure […]
July 21 Biotech Update
The sector was green again yesterday and this morning but it does not seem to be a broad based move. The small caps appear to be underperforming and among the large caps it seems isolated to CELG with AMGN and GILD being relatively weak. This narrowing of the move tells me that we are much […]
July 20 Biotech Update
There is some news this morning but nothing that in and of itself is likely to move the sector. On the other hand, the news has generally been positive, so there is nothing to change the momentum to the upside. It is nice to see a week begin without a major macro discussion. Perhaps this […]
[Free Report] Endo Makes Bid For Auxilium; Gilead Fails Pancreatic Cancer Trial
Endo International made an unsolicited proposal yesterday to acquire all the outstanding shares of Auxilium Pharmaceuticals for $28.10 per share in a mixed cash and stock transaction valuing the company at $2.2 billion. Endo intends on funding the deal with existing cash as well as debt financing. Endo expects the addition of Auxilium to be […]
February 19 Biotech Update- Talking Gene Therapy
We have had a strong couple of days and clearly the biotech rally is in continuation mode but I still would not be surprised to see a day or two like today where it rests a little. Keep in mind that the IBB index is essentially an index of large cap biotechs and will move […]
Jan 8 Biotech Update- Looking to Europe for Value and Some Deals at Home
Well, it seemed like yesterday was the day of good data and today was the day of buyouts, what will tomorrow bring? The day of partnerships or the calm before the storm or something completely different? Regardless, two days of good news in the sector gave us a strong morning move that held up well […]
